Becker's ASC Review

41 GASTROENTEROLOGY Ascension Seton, UT Health Austin open GI practice By Eric Oliver A ustin, Texas-based providers Ascension Seton and UT Health Austin created a clinical partner- ship to offer gastrointestinal care, UT Health announced Sept. 24. The program will offer gastroenterology diagnostic and surgery services through a clinic in Austin. Digestive Health will be led by Medical Director Deepak Agrawal, MD, and Surgical Director F. Paul Buckley, MD. n Dr. Conor Delaney appointed president, CEO of Cleveland Clinic Florida region By Eric Oliver C olorectal surgeon Conor Delaney, MD, PhD, has been named president and CEO of the Cleve- land Clinic Florida region effective Oct. 15. Dr. Delaney is currently chair of the Cleveland Clinic's Digestive Disease and Surgical Institute. He oversees more than 240 staff physicians, more than 80 advanced practice providers, and 140 residents and fellows. The team performs 48,000 surgical cases and 90,000 endo- scopic procedures annually. He joined Cleveland Clinic in 1999 as a fellow and be- gan his career in 2000 on the clinical associate staff. Dr. Delaney notably has published more than 450 lectures nationally and internationally and has published 15 books and 400 original manuscripts, reviews and chapters. Current CEO and President Joseph Iannotti, MD, PhD, will continue in his roles as chief of staff and chief academic and innovation officer once Dr. Delaney takes over. n FDA allowing at-home use of CapsoCam Plus device By Eric Oliver T he FDA applied a labeling addendum for Capso- Vision's CapsoCam Plus, which will allow for at- home administration of the device. CapsoCam Plus is a small bowel capsule endoscope. The labeling addendum will allow for fully remote cap- sule endoscopy procedures. The change will eliminate the need for in-person interaction between physicians and patients. CapsoCam Plus is the only capsule endoscopy system that doesn't require external equipment. The patient ingests the capsule, resumes daily activities while exam data is being captured, and returns the device eight to 12 hours later, where it will be disinfected between uses. Physicians can use the CapsoCloud cloud-based soft- ware to review the images captured by the device. n Gut microbiota, managing inflammation may battle CRC By Eric Oliver A ltering microorganisms in the intestine and managing inflammation may prevent colorectal cancer, according to findings from Gainesville- based University of Florida researchers. Abnormal microbiota contributes to inflammation and CRC development. Researchers studied how managing inflammation with an anti-inflammatory treatment would affect colon cancer development in mice. Researchers gave mice with colon cancer anti-tumor necrosis factor, a therapy used to treat inflammatory bowel disease. When mice received the anti-TNF therapy, it lessened inflammation and colon cancer development. Researchers are building on the research to look for microbial genes or pathways that affect cancer develop- ment. They said more work is needed to understand the relationship between therapies, microbiota and cancer development. n

• Cover